Triggering Immune System With Nanomaterials for Cancer Immunotherapy
Cancer is a major cause of incidence rate and mortality worldwide. In recent years, cancer immunotherapy has made great progress in the preclinical and clinical treatment of advanced malignant tumors. However, cancer patients will have transient cancer suppression reaction and serious immune related...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2022-04-01
|
| Serija: | Frontiers in Bioengineering and Biotechnology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.878524/full |
| Oznake: |
Brez oznak, prvi označite!
|